140 related articles for article (PubMed ID: 19757195)
1. Is predisposition for nephroblastoma linked to polymorphisms of the WTX gene?
Guertl B; Leuschner I; Guelly C; Ebner B; Kronberger C; Hoefler G
Pathol Oncol Res; 2010 Jun; 16(2):189-91. PubMed ID: 19757195
[TBL] [Abstract][Full Text] [Related]
2. WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact.
Wegert J; Wittmann S; Leuschner I; Geissinger E; Graf N; Gessler M
Genes Chromosomes Cancer; 2009 Dec; 48(12):1102-11. PubMed ID: 19760609
[TBL] [Abstract][Full Text] [Related]
3. An X chromosome gene, WTX, is commonly inactivated in Wilms tumor.
Rivera MN; Kim WJ; Wells J; Driscoll DR; Brannigan BW; Han M; Kim JC; Feinberg AP; Gerald WL; Vargas SO; Chin L; Iafrate AJ; Bell DW; Haber DA
Science; 2007 Feb; 315(5812):642-5. PubMed ID: 17204608
[TBL] [Abstract][Full Text] [Related]
4. Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors.
Ruteshouser EC; Robinson SM; Huff V
Genes Chromosomes Cancer; 2008 Jun; 47(6):461-70. PubMed ID: 18311776
[TBL] [Abstract][Full Text] [Related]
5. Identification and analysis of mutations in WTX and WT1 genes in peripheral blood and tumor tissue of children with Wilms' tumor.
Wang H; Shen Y; Sun N; Jiang YP; Li ML; Sun L
Chin Med J (Engl); 2012 May; 125(10):1733-9. PubMed ID: 22800892
[TBL] [Abstract][Full Text] [Related]
6. Different incidences of epigenetic but not genetic abnormalities between Wilms tumors in Japanese and Caucasian children.
Haruta M; Arai Y; Watanabe N; Fujiwara Y; Honda S; Ohshima J; Kasai F; Nakadate H; Horie H; Okita H; Hata J; Fukuzawa M; Kaneko Y
Cancer Sci; 2012 Jun; 103(6):1129-35. PubMed ID: 22409817
[TBL] [Abstract][Full Text] [Related]
7. Inheritance of susceptibility to induction of nephroblastomas in the Noble rat.
Diwan BA; Timofeeva O; Rice JM; Yang Y; Sharma N; Fortini ME; Wang H; Perantoni AO
Differentiation; 2009 Apr; 77(4):424-32. PubMed ID: 19281789
[TBL] [Abstract][Full Text] [Related]
8. WTX mutations can occur both early and late in the pathogenesis of Wilms tumour.
Fukuzawa R; Holman SK; Chow CW; Savarirayan R; Reeve AE; Robertson SP
J Med Genet; 2010 Nov; 47(11):791-4. PubMed ID: 20679664
[TBL] [Abstract][Full Text] [Related]
9. WT1, WTX and CTNNB1 mutation analysis in 43 patients with sporadic Wilms' tumor.
Cardoso LC; De Souza KR; De O Reis AH; Andrade RC; Britto AC; De Lima MA; Dos Santos AC; De Faria PS; Ferman S; Seuánez HN; Vargas FR
Oncol Rep; 2013 Jan; 29(1):315-20. PubMed ID: 23117548
[TBL] [Abstract][Full Text] [Related]
10. Wilms' tumor with an apparently balanced translocation t(X;18) resulting in deletion of the WTX gene.
Han M; Rivera MN; Batten JM; Haber DA; Dal Cin P; Iafrate AJ
Genes Chromosomes Cancer; 2007 Oct; 46(10):909-13. PubMed ID: 17620295
[TBL] [Abstract][Full Text] [Related]
11. Wilms tumor genetics: a new, UnX-pected twist to the story.
Huff V
Cancer Cell; 2007 Feb; 11(2):105-7. PubMed ID: 17292822
[TBL] [Abstract][Full Text] [Related]
12. Functional inactivation of the WTX gene is not a frequent event in Wilms' tumors.
Perotti D; Gamba B; Sardella M; Spreafico F; Terenziani M; Collini P; Pession A; Nantron M; Fossati-Bellani F; Radice P
Oncogene; 2008 Jul; 27(33):4625-32. PubMed ID: 18391980
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of Wilms tumor-suppressor WTX and tumor-associated mutants.
Kim MK; Min DJ; Rabin M; Licht JD
Oncogene; 2011 Feb; 30(7):832-42. PubMed ID: 20956941
[TBL] [Abstract][Full Text] [Related]
14. Germline mutations in WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis.
Jenkins ZA; van Kogelenberg M; Morgan T; Jeffs A; Fukuzawa R; Pearl E; Thaller C; Hing AV; Porteous ME; Garcia-Miñaur S; Bohring A; Lacombe D; Stewart F; Fiskerstrand T; Bindoff L; Berland S; Adès LC; Tchan M; David A; Wilson LC; Hennekam RC; Donnai D; Mansour S; Cormier-Daire V; Robertson SP
Nat Genet; 2009 Jan; 41(1):95-100. PubMed ID: 19079258
[TBL] [Abstract][Full Text] [Related]
15. [The tumor suppressor gene WTX, mutated in Wilms tumours, is a member of the beta-catenin destruction complex].
Angers S
Med Sci (Paris); 2007 Nov; 23(11):1025-7. PubMed ID: 18021721
[No Abstract] [Full Text] [Related]
16. Is WTX a suitable target for cancer therapy?
Perotti D; Radice P
Pediatr Blood Cancer; 2011 Apr; 56(4):682. PubMed ID: 21298763
[No Abstract] [Full Text] [Related]
17. Inactivation of the tumor suppressor WTX in a subset of pediatric tumors.
Akhavanfard S; Vargas SO; Han M; Nitta M; Chang CB; Le LP; Fazlollahi L; Nguyen Q; Ma Y; Cosper A; Dias-Santagata D; Han JY; Bergethon K; Borger DR; Ellisen LW; Pomeroy SL; Haber DA; Iafrate AJ; Rivera MN
Genes Chromosomes Cancer; 2014 Jan; 53(1):67-77. PubMed ID: 24249259
[TBL] [Abstract][Full Text] [Related]
18. Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene.
Huff V
Nat Rev Cancer; 2011 Feb; 11(2):111-21. PubMed ID: 21248786
[TBL] [Abstract][Full Text] [Related]
19. Clinical, Pathologic, and Genetic Features of Wilms Tumors With WTX Gene Mutation.
Alexandrescu S; Akhavanfard S; Harris MH; Vargas SO
Pediatr Dev Pathol; 2017; 20(2):105-111. PubMed ID: 28326956
[TBL] [Abstract][Full Text] [Related]
20. Canonical WNT signalling determines lineage specificity in Wilms tumour.
Fukuzawa R; Anaka MR; Weeks RJ; Morison IM; Reeve AE
Oncogene; 2009 Feb; 28(8):1063-75. PubMed ID: 19137020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]